Tacit Therapeutics
PrivateLast Round
Series A
Mar 9, 2026
Total Funding Raised
$29.5M
Momentum Score
50 /100
Company Overview
Tacit Therapeutics is a biotechnology company that develops RNA-targeted treatments to repair mutated genes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
RNA repairRNA editingRNA trans-splicingSplicing-Directed Repairgene therapyRNA therapeuticsprogrammable medicinegenetic diseasesrare disease therapysplicing modulationrare neurological disordersDravet syndromeRett syndromepreclinical drug developmentSmall Business Innovation ResearchSBIR
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tacit Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Tacit Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 9, 2026 | ||||
| Grant | Jan 15, 2024 | ||||
| Series A | Jun 8, 2022 |
Tacit Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eisai Innovation | Series A |
| Michigan Capital Network | Series A |
| Civilization Ventures | Series A |
| KdT Ventures | Series A |
| National Science Foundation | Grant |
Tacit Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tacit Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersSouth San Francisco, California
Employee Range12
Year Founded2021
Last FundingMar 9, 2026
